Compass Therapeutics Inc Ordinary Shares (NASDAQ:CMPX)

North American company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - CMPX

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - CMPX

  • Market Cap$0.000m
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS20454B1044

Company Profile

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is developing proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. Its pipeline product candidates are CTX-471/ CD137 agonist, CTX-8371, and CTX-8573.

Latest CMPX news

Currently there for this company. Visit our news hub for other news .